SMN1 and proximal spinal muscular atrophy: Data from an experimental SMA model demonstrated that LPS administration, in addition to inducing a strong inhibition of exon 7 inclusion in the SMN2 gene transcript, resulting in a decrease of SMN protein levels in both peripheral and CNS tissues, also promoted the rapid development of systemic inflammation [42].